Abstract
Respiratory syncytial virus, one of the most common causes of respiratory infections in immunocompetent individuals, is frequently spread to recipients of HSCT by family members, other patients, and health care workers. In immunosuppressed individuals, progression from upper respiratory tract disease to pneumonia is common, and usually fatal if left untreated. We performed a retrospective analysis of RSV infections in recipients of autologous or allogeneic transplants. The incidence of RSV following allogeneic or autologous HSCT was 5.7% and 1.5%, respectively. Of the 58 patients with an RSV infection, 16 of 21 patients identified within the first post-transplant month, developed pneumonia. Seventy-two percent of patients received aerosolized ribavirin and/or RSV-IGIV, including 23 of 25 patients diagnosed with RSV pneumonia. In this aggressively treated patient population, three patients died of RSV disease, each following an unrelated HSCT.
Bone Marrow Transplantation (2002) 29, 321–327. doi:10.1038/sj.bmt.1703365
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Domachowske JB, Rosenberg HF . Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment Clin Microbiol Rev 1999 12: 298 309
Hall SB . Respiratory syncytial virus and parainfluenza virus New Engl J Med 2001 344: 1917 1928
Glezen WP, Taber LH, Frank AL, Kasel JA . Risk of primary infection and reinfection with respiratory syncytial virus Am J Dis Child 1986 140: 543 546
Falsey AR, Walsh EE . Respiratory syncytial virus in adults Clin Microbiol Rev 2000 13: 371 384
Hall CB, Walsh EE, Long CE, Schnabel KC . Immunity to and frequency of reinfection with respiratory syncytial virus J Infect Dis 1997 163: 693 698
Hall CB, Geiman JM, Biggar R et al. Respiratory syncytial virus infections within families New Engl J Med 1979 294: 414 419
Prober CG, Sullender WM . Advances in prevention of respiratory syncytial virus infections J Pediatr 1999 135: 546 558
Hall CB . Nosocomial respiratory syncytial virus infections: the ‘Cold War’ has not ended Clin Infect Dis 2000 31: 590 596
Harrington RD, Hooton TM, Hackman RC et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center J Infect Dis 1992 165: 987 993
Whimbey E, Champlin RE, Englund JA et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients Bone Marrow Transplant 1995 16: 393 399
Couch RB, England JA, Whimbey E . Respiratory viral infections in immunocompetent and immunocompromised persons Am J Med 1997 102: 2 9
Bowden RA . Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience Am J Med 1997 102: 27 30
Ghosh S, Champlin RE, Englund J et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin Bone Marrow Transplant 2000 25: 751 755
Aslan T, Fassas AB-T, Desikan R et al. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy Bone Marrow Transplant 1999 24: 505 509
Collins NH, Bleau SA, Kernan NA, O'Reilly RJ . T cell depletion of bone marrow by treatment with soybean agglutinin and sheep red blood cell rosetting In: Areman HJ, Deeg HJ, Sacher RA (eds) Bone Marrow and Stem Cell Processing: A Manual of Current Techniques FA Davis: Philadelphia, PA 1992 p 171
Casper J, Camitta B, Truitt R et al. Unrelated bone marrow transplants for children with leukemia or myelodysplasia Blood 1995 85: 2354 2363
Collins NH, Fernandez JM, Bleau S et al. Comparison of bone marrow and G-CSF mobilized peripheral blood progenitor cells from single normal donors before and after T cell depletion Cytotherapy 1999 1: 223
McCarthy AJ, Kingman HM, Kelly C et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation Bone Marrow Transplant 1999 24: 1315 1322
DeVincenzo JP, Hirsch RL, Fuentes RJ, Top FH Jr . Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation – a compassionate use experience Bone Marrow Transplant 2000 25: 161 165
Crooks BNA, Taylor CE, Turner AJL et al. Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit Bone Marrow Transplant 2000 26: 1097 1102
Khushalani NI, Bakri FG, Wentling D et al. Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review Bone Marrow Transplant 2001 27: 1071 1073
Acknowledgements
This work was supported by PO1 CA23766 from the National Cancer Institute, National Institute of Health.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Small, T., Casson, A., Malak, S. et al. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant 29, 321–327 (2002). https://doi.org/10.1038/sj.bmt.1703365
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703365
Keywords
This article is cited by
-
Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis
Advances in Therapy (2022)
-
Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases
Infectious Diseases and Therapy (2017)
-
Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized Problem
Drugs & Aging (2015)
-
Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation
Current Infectious Disease Reports (2015)
-
Genetic Vaccine for Respiratory Syncytial Virus Provides Protection Without Disease Potentiation
Molecular Therapy (2014)